Leading Alzheimer’s disease expert Charles DeCarli, M.D., joins DiaGenic’s Scientific Advisory Board
Monday, 27 May 2013
Medical company, DiaGenic announced the appointment of Charles DeCarli, M.D., to its Scientific Advisory Board.
According to a press release, Dr. DeCarli is a renowned scientist
and physician whose research focuses on using advanced structural and
functional brain imaging to study normal aging, mild cognitive
impairment and dementia and the role of genetics, cerebrovascular and
Alzheimer's disease on these processes.
by scancomark.com Team
want to contribute to our news network? Do have a news
tip or assist us with a correction? Please ...